# Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)

> **NCT04707261** · PHASE4 · RECRUITING · sponsor: **Xiangtan Central Hospital** · enrollment: 1990 (estimated)

## Conditions studied

- Anemia
- Heart Failure

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04707261
- **Lead sponsor:** Xiangtan Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-06
- **Primary completion:** 2025-05-05
- **Final completion:** 2026-01-01
- **Target enrollment:** 1990 (ESTIMATED)
- **Last updated:** 2024-07-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04707261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04707261, "Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04707261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*